RCEL · Insider Trading
Avita Medical, Inc. Common Stock
Every open-market purchase and sale reported by RCEL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | David D O'Toole | CFO | Buy | +2,000 | +$7.94K |
| 2026-06-12 | David D O'Toole | CFO | A | +2,000 | +$7.94K |
| 2026-06-10 | Joseph Fralin Woody | Director | Buy | +5,200 | +$20.80K |
| 2026-06-09 | Joseph Fralin Woody | Director | Buy | +10,000 | +$41.90K |
| 2026-06-05 | Joseph Fralin Woody | Director | Buy | +10,000 | +$40.95K |
| 2026-06-04 | Robert McNamara | Director | A | +22,214 | — |
| 2026-06-04 | Jeremy Curnock Cook | Director | A | +22,214 | — |
| 2026-06-04 | Michael E Tarnoff | Director | A | +48,464 | — |
| 2026-06-04 | Suzanne Crowe | Director | A | +22,214 | — |
| 2026-06-04 | Jan Stern Reed | Director | A | +22,214 | — |
| 2026-06-04 | Joseph Fralin Woody | Director | A | +62,761 | — |
| 2026-06-03 | Joseph Fralin Woody | Director | Buy | +20,000 | +$84.94K |
| 2026-06-01 | David D O'Toole | CFO | A | +5,000 | +$15.26K |
| 2026-06-01 | Cary Guy Vance | President and CEO | A | +5,000 | +$15.26K |
| 2026-05-20 | David D O'Toole | CFO | Buy | +2,000 | +$8.52K |
| 2026-05-19 | David D O'Toole | CFO | Buy | +2,000 | +$8.48K |
| 2026-03-11 | David D O'Toole | CFO | Buy | +1,800 | +$8.60K |
| 2026-02-23 | David D O'Toole | CFO | Buy | +3,000 | +$12.45K |
| 2026-02-19 | Nicole Kelsey | Chief Legal Officer | A | +98,390 | — |
| 2026-02-19 | David D O'Toole | CFO | A | +105,470 | — |
| 2025-08-29 | Robert McNamara | Director | Buy | +10,000 | +$45.00K |
| 2025-08-26 | David D O'Toole | CFO | Buy | +2,000 | +$9.04K |
| 2025-08-20 | Robert McNamara | Director | Buy | +10,000 | +$50.00K |
| 2025-08-12 | David D O'Toole | CFO | Buy | +2,000 | +$9.62K |
| 2025-06-05 | Robert McNamara | Director | A | +10,022 | — |
| 2025-06-05 | Suzanne Crowe | Director | A | +10,022 | — |
| 2025-06-05 | Cary Guy Vance | Director | A | +10,022 | — |
| 2025-06-05 | Jeremy Curnock Cook | Director | A | +10,022 | — |
| 2025-06-05 | James Corbett | CEO | A | +520,000 deriv. | — |
| 2025-06-05 | Jan Stern Reed | Director | A | +10,022 | — |
| 2025-06-05 | Lou Panaccio | Director | A | +10,022 | — |
| 2025-06-02 | David D O'Toole | CFO | A | +1,923 | +$9.19K |
| 2025-03-10 | Robert McNamara | Director | Buy | +11,000 | +$91.30K |
| 2025-02-20 | Robert McNamara | Director | Buy | +10,000 | +$100.90K |
| 2025-02-20 | David D O'Toole | CFO | Buy | +1,000 | +$9.90K |
| 2025-02-19 | David D O'Toole | CFO | Buy | +1,000 | +$10.25K |
| 2025-01-29 | Suzanne Crowe | Director | Buy | +486 | +$6.39K |
| 2025-01-22 | Nicole Kelsey | Chief Legal Officer | A | +65,000 deriv. | — |
| 2025-01-22 | David D O'Toole | CFO | A | +150,000 deriv. | — |
| 2024-12-05 | David D O'Toole | CFO | MIXED | +1,760 | +$18.30K |
| 2024-08-20 | Robert McNamara | Director | A | +10,000 | +$90.00K |
| 2024-06-06 | Suzanne Crowe | Director | A | +9,200 | — |
| 2024-06-06 | James Corbett | CEO | A | +350,000 deriv. | — |
| 2024-06-06 | Jan Stern Reed | Director | A | +9,200 | — |
| 2024-06-06 | Robert McNamara | Director | A | +9,200 | — |
| 2024-06-06 | Jeremy Curnock Cook | Director | A | +9,200 | — |
| 2024-06-06 | Cary Guy Vance | Director | A | +9,200 | — |
| 2024-06-06 | Lou Panaccio | Director | A | +9,200 | — |
| 2024-06-03 | Donna Shiroma | General Counsel | A | +2,225 | +$18.17K |
| 2024-06-03 | David D O'Toole | CFO | MIXED | +3,240 | +$27.20K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| David D O'Toole | CFO | 152,927 | $2.32M |
| Robert McNamara | Director | 108,985 | $1.65M |
| Joseph Fralin Woody | Director | 107,961 | $1.64M |
| Nicole Kelsey | Chief Legal Officer | 98,390 | $1.49M |
| Jan Stern Reed | Director | 73,225 | $1.11M |
| Suzanne Crowe | Director | 69,148 | $1.05M |
| Lou Panaccio | Director | 62,400 | $947.23K |
| Jeremy Curnock Cook | Director | 62,050 | $941.92K |
| Cary Guy Vance | President and CEO | 40,771 | $618.90K |
| Michael E Tarnoff | Director | 26,250 | $398.48K |
| James Corbett | CEO | 11,580 | $175.78K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the RCEL quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.